🇺🇸 FDA
Pipeline program

Metabolically Armed CD19 CAR-T cells

Meta10-19-004

Phase 1 small_molecule active

Quick answer

Metabolically Armed CD19 CAR-T cells for Acute Lymphoblastic Leukemia is a Phase 1 program (small_molecule) at Anhui Provincial Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Anhui Provincial Hospital
Indication
Acute Lymphoblastic Leukemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials